Spring Bank Pharmaceuticals Inc. named Scott Smith to be the company's chairman, effective Jan. 1, 2019.

Smith will replace Martin Driscoll, who will continue as the company's president and CEO.

Meanwhile, Christiana Bardon stepped down as a director of the U.S.-based clinical-stage biopharmaceutical company.